These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14661922)

  • 1. Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes.
    Zhang YF; Boado RJ; Pardridge WM
    Pharm Res; 2003 Nov; 20(11):1779-85. PubMed ID: 14661922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
    Zhang Y; Calon F; Zhu C; Boado RJ; Pardridge WM
    Hum Gene Ther; 2003 Jan; 14(1):1-12. PubMed ID: 12573054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):129-38. PubMed ID: 15717064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread expression of an exogenous gene in the eye after intravenous administration.
    Zhu C; Zhang Y; Pardridge WM
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3075-80. PubMed ID: 12202532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.
    Shi N; Boado RJ; Pardridge WM
    Pharm Res; 2001 Aug; 18(8):1091-5. PubMed ID: 11587478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
    Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked enhancement in gene expression by targeting the human insulin receptor.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Feb; 5(2):157-63. PubMed ID: 12539153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice.
    Zhu C; Zhang Y; Zhang YF; Yi Li J; Boado RJ; Pardridge WM
    J Gene Med; 2004 Aug; 6(8):906-12. PubMed ID: 15293349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy.
    Zhang Y; Pardridge WM
    Pharm Res; 2009 May; 26(5):1059-63. PubMed ID: 19104914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation.
    Chu C; Zhang Y; Boado RJ; Pardridge WM
    Pharm Res; 2006 Jul; 23(7):1586-90. PubMed ID: 16779704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.
    Xia CF; Boado RJ; Zhang Y; Chu C; Pardridge WM
    J Gene Med; 2008 Mar; 10(3):306-15. PubMed ID: 18085726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes.
    Zhao H; Li GL; Wang RZ; Li SF; Wei JJ; Feng M; Zhao YJ; Ma WB; Yang Y; Li YN; Kong YG
    J Int Med Res; 2010; 38(3):957-66. PubMed ID: 20819432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes.
    Cornford EM; Hyman S; Cornford ME; Chytrova G; Rhee J; Suzuki T; Yamagata T; Yamakawa K; Penichet ML; Pardridge WM
    J Drug Target; 2016; 24(1):58-67. PubMed ID: 26133964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
    Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
    J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive gene targeting to the brain.
    Shi N; Pardridge WM
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7567-72. PubMed ID: 10840060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.